Zepbound (tirzepatide), Eli Lilly’s GLP-1/GIP dual receptor agonist, is approved for chronic weight management and, more recently, for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It carries a list price of roughly $1,000 or more per month (list prices change, so treat this as an estimate). With insurance coverage for anti-obesity medications still inconsistent across plans, many patients are searching for Zepbound discounts to make the treatment affordable. Multiple savings pathways exist, from manufacturer programs to third-party discount tools, and knowing which options apply to your situation can save you hundreds or thousands of dollars. This article is general information, not medical or financial advice, and it is not affiliated with or endorsed by Eli Lilly; treatment decisions belong to you and your prescriber, and prices and programs change frequently – verify current details at the official source.
Eli Lilly’s Zepbound Savings Card
For people who qualify, some of the most substantial Zepbound discounts come directly from Eli Lilly. The Zepbound Savings Card is available to commercially insured patients whose insurance covers the drug. With the savings card, eligible patients may pay as little as $25 for a 1-month, 2-month, or 3-month fill, subject to per-fill maximum savings and an annual savings cap that Lilly sets and periodically updates (recent terms have capped savings at a few hundred dollars per fill and around $1,300 per year – confirm the current amounts on Lilly’s site). The pharmacy processes your insurance first, and the savings card reduces a portion of the remaining copay or coinsurance.
To activate the savings card, visit the official Zepbound website or call Lilly at 1-800-545-6962. You will need to provide basic personal information and your insurance details, then present the card at the pharmacy along with your insurance information. Terms, maximums, and eligibility can change, so read the current fine print before you rely on a specific figure.
This savings card cannot be used by patients with government insurance, including Medicare, Medicare Part D, Medicare Advantage, Medicaid, or Tricare. It is exclusively for patients with commercial or employer-sponsored health coverage.
Zepbound for Cash-Pay Patients (LillyDirect)
Eli Lilly offers a direct self-pay option for patients paying without insurance coverage for Zepbound. Through LillyDirect, the company’s online pharmacy platform, eligible cash-pay patients have been able to buy Zepbound at prices well below the list price – recently in the range of roughly $299 to $449 per month depending on the dose (lower strengths have been priced lower than higher strengths). These prices have changed several times since the program launched, so verify the current self-pay pricing directly on LillyDirect before assuming a figure.
The LillyDirect experience can include a telehealth consultation, home delivery, and customer support. Patients complete an online health assessment, and if an independent prescriber determines that Zepbound is appropriate, the medication is shipped to the patient’s home. This option is particularly valuable for patients whose insurance plans exclude anti-obesity medications entirely. Availability of specific doses and formats (for example, single-dose vials versus pens) can vary over time.
Lilly Cares Patient Assistance Program
For patients with limited income who lack insurance coverage, the Lilly Cares Foundation Patient Assistance Program (PAP) may provide Zepbound at no cost. Eligibility generally requires U.S. residency, a household income at or below a set percentage of the Federal Poverty Level (often cited around 400% FPL – verify the current threshold and dollar figures), and no prescription drug insurance coverage for the medication.
The application process involves your healthcare provider completing an enrollment form and submitting it with your proof of income; processing typically takes a few weeks. Approved patients generally receive medication through the program’s designated channel. Contact Lilly Cares at 1-800-545-6962 for current forms, income limits, and instructions. This is distinct from the savings card and serves a different patient population.
Insurance Coverage Landscape
Insurance coverage for Zepbound remains a moving target. Many commercial insurers cover GLP-1 receptor agonists prescribed for weight management, though some require prior authorization, step therapy (trying lifestyle changes or other medications first), or impose quantity limits, and some employer-sponsored plans explicitly exclude anti-obesity medications. Coverage for the newer OSA indication may follow different rules than coverage for weight management, so it is worth checking both.
Medicare Part D has historically not covered drugs prescribed solely for weight loss, though coverage may be possible when the drug is prescribed for a separately covered indication; policy in this area has been the subject of ongoing proposals and rule changes, so confirm the current status. If you have Medicare, see our guide on Medicare coverage of weight-loss drugs for context. Medicaid coverage varies by state, with some states covering GLP-1 agonists for weight management and others excluding them.
If your insurance denies coverage, request the denial in writing and file an appeal. Include clinical documentation from your prescriber explaining the medical necessity of Zepbound based on your diagnosis, BMI, comorbid conditions (such as OSA), and prior treatment history. Many initial denials are overturned on appeal. For broader coverage strategies, see our healthcare policy guide.
Third-Party Discount Options and Compounding Caution
Beyond manufacturer programs, several third-party tools advertise Zepbound discounts. GoodRx and other prescription discount cards may provide modest savings on the cash price of Zepbound at participating pharmacies. However, because Zepbound is a brand-name specialty medication, third-party discounts are typically smaller than what the manufacturer offers directly. A discount card is not insurance, and you generally cannot combine a manufacturer copay card with a discount card on the same fill.
A note on compounded tirzepatide: During the earlier tirzepatide shortage, some compounding pharmacies and telehealth sellers offered lower-priced “compounded” versions. After the FDA determined the shortage was resolved, large-scale compounding of tirzepatide was required to wind down over 2025. Compounded versions are not FDA-approved, do not undergo the same review for safety, effectiveness, and quality, and continued gray-market sales carry real risks, including unregulated or counterfeit products. Be cautious of online sellers still marketing cheap “compounded tirzepatide,” and discuss any such product with your prescriber before using it.
Comparing Zepbound to Alternatives
Zepbound is not the only GLP-1-based weight management medication on the market. Wegovy (semaglutide), made by Novo Nordisk, is approved for chronic weight management and has its own savings programs and self-pay options. Both manufacturers offer savings cards for commercially insured patients, and both have introduced cash-pay pathways, so it is worth comparing net out-of-pocket cost after discounts for each.
The choice between Zepbound and Wegovy often comes down to clinical response, side-effect profile, the specific indication, and which medication your insurance covers at a lower tier. Your prescriber can help determine which medication is the best clinical and financial fit for you.
Strategies for Maximizing Savings
Start by checking your insurance formulary for Zepbound coverage and tier placement. If it is covered, activate the manufacturer savings card to lower your copay (if you have commercial insurance). If it is not covered, file an appeal with clinical justification. While waiting for an appeal decision, explore the LillyDirect self-pay option at its reduced price.
If your income qualifies, apply for the Lilly Cares PAP for free medication. Combine these efforts with general prescription savings strategies from our healthcare costs guide. Some patients also reduce costs by using employer Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) to pay for Zepbound with pre-tax dollars where eligible.
Frequently Asked Questions
Does Medicare cover Zepbound?
Medicare Part D has historically not covered medications prescribed solely for weight loss. If Zepbound is prescribed for a separately covered indication (such as moderate-to-severe obstructive sleep apnea in adults with obesity), coverage may be possible, subject to plan rules. Policy in this area continues to evolve, so verify the current status with your plan; the manufacturer savings card is not available to people with Medicare.
How much does Zepbound cost without insurance?
The list price is roughly $1,000 or more per month. Through LillyDirect, cash-pay patients have recently been able to access Zepbound for approximately $299-$449 per month depending on the strength (verify current pricing). Retail pharmacy prices without any program are close to the list price, and a discount card may reduce the retail price only modestly.
Can I get Zepbound for free?
Possibly, through the Lilly Cares Patient Assistance Program, if you meet income and coverage eligibility requirements (generally no insurance coverage for the drug and income below a set threshold). Contact Lilly Cares at 1-800-545-6962 for current criteria and to apply.
Are Zepbound discounts available for all dosages?
Manufacturer programs generally cover the available dosage strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg), but self-pay prices can differ by strength, and savings-card maximums and eligibility can vary. Check the current terms for your specific dose.
What if my pharmacy does not accept the savings card?
The Zepbound Savings Card is accepted at many retail and specialty pharmacies. If your pharmacy does not accept it, call the number on the card for help finding a participating pharmacy, or consider LillyDirect for home delivery.
Take Control of Your Zepbound Costs
Zepbound is a clinically significant medication, and cost should not be the only barrier to appropriate treatment. Between manufacturer savings cards, the LillyDirect self-pay option, the Lilly Cares PAP, insurance appeals, and third-party discount tools, multiple pathways exist to bring the cost down. Start by contacting Lilly at 1-800-545-6962 or visiting the official Zepbound website, verify the current prices and terms, and pair those resources with the comprehensive strategies in our healthcare costs guide – all in coordination with your prescriber.
Disclaimer: This article is general information, not medical or financial advice, and it does not provide dosing guidance. Free Market Healthcare is not affiliated with, sponsored by, or endorsed by Eli Lilly and Company; Zepbound and LillyDirect are trademarks of their owner. Manufacturer savings cards, patient assistance programs, and discount cards are not insurance, and eligibility rules exclude many patients (for example, the savings card excludes people with Medicare, Medicaid, or other government coverage). Prices, programs, and coverage change frequently and vary by plan and pharmacy – verify all figures at the official source before relying on them. Do not use non-FDA-approved compounded tirzepatide from unverified sellers. Decisions about starting, continuing, or changing Zepbound should be made with your prescriber.
Sources
- Eli Lilly – Zepbound coverage and savings pages, including the Zepbound Savings Card terms (zepbound.lilly.com)
- LillyDirect – Lilly’s self-pay pharmacy and self-pay Zepbound pricing (lillydirect.lilly.com)
- Lilly Cares Foundation – Patient Assistance Program eligibility and application information (1-800-545-6962)
- U.S. Food and Drug Administration (FDA) – statements on resolution of the tirzepatide shortage and limits on compounding
- Medicare.gov and CMS – Part D coverage rules for anti-obesity and weight-management medications